↓ Skip to main content

Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden

Overview of attention for article published in Frontiers in oncology, April 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
30 Mendeley